Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization
Connexin 43 (Cx43), a vital gap junction protein in tumor microenvironment (TME), is a novel molecular target for melanoma chemotherapeutics due to its tumor suppressive function. Dioscin, an herbal steroidal saponin, exerts anti‐tumor effects while the underlying mechanism is unclear. Using WB, FAC...
Saved in:
Published in | International journal of cancer Vol. 141; no. 8; pp. 1690 - 1703 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
15.10.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0020-7136 1097-0215 1097-0215 |
DOI | 10.1002/ijc.30872 |
Cover
Loading…
Abstract | Connexin 43 (Cx43), a vital gap junction protein in tumor microenvironment (TME), is a novel molecular target for melanoma chemotherapeutics due to its tumor suppressive function. Dioscin, an herbal steroidal saponin, exerts anti‐tumor effects while the underlying mechanism is unclear. Using WB, FACS, and immunofluorescence methodologies, we found dioscin significantly activated the transcription and translation of Cx43 via the retinoid acid signaling pathway and simultaneously enhanced the transporting function of Cx43. Through stimulating Cx43, dioscin remarkably suppressed the migratory and invasive capacities of B16 cells, and notably decreased pluripotency markers of cancer stem cells and epithelial‐to‐mesenchymal transition in B16 cells and animal tumor tissues. Conversely, dioscin improved the secretion of pro‐inflammatory cytokines (IL‐6, TNFα, and IL‐1β), and the phagocytic capacity of tumor‐associated macrophages by increasing M2‐to‐M1 phenotype transition. More strikingly, even in Cx43 functional deficient B16 and RAW264.7 cells, dioscin still dramatically reversed the aggravated tumor malignancy and reduced macrophage phagocytic activity. Two classical metastasis animal models were utilized in vivo and results showed that dioscin showed significant anti‐metastatic effects, which is closely related to the expression of Cx43 either in in situ tumor or metastatic lung nodes. In conclusion, dioscin targets Cx43 to suppress the tumor cell malignancy and activate macrophage sensitivity, thereby targeting melanoma microenvironment.
What's new?
New results reveal how an Chinese herbal medicine component acts against melanoma. Dioscin, a natural steroidal saponin, induces apoptosis in breast cancer as well as boosting production of pro‐inflammatory cytokines. These authors investigated the chemical's effect on connexin 43, a tumor suppressing protein found in the microenvironment that is frequently silenced in metastatic melanoma. Dioscin remarkably enhanced the expression of connexin 43, as well as boosting its ability to reverse the metastatic transition. Treatment with dioscin also enhanced the immune response, spurring macrophages to attack the tumor cells. |
---|---|
AbstractList | Connexin 43 (Cx43), a vital gap junction protein in tumor microenvironment (TME), is a novel molecular target for melanoma chemotherapeutics due to its tumor suppressive function. Dioscin, an herbal steroidal saponin, exerts anti‐tumor effects while the underlying mechanism is unclear. Using WB, FACS, and immunofluorescence methodologies, we found dioscin significantly activated the transcription and translation of Cx43 via the retinoid acid signaling pathway and simultaneously enhanced the transporting function of Cx43. Through stimulating Cx43, dioscin remarkably suppressed the migratory and invasive capacities of B16 cells, and notably decreased pluripotency markers of cancer stem cells and epithelial‐to‐mesenchymal transition in B16 cells and animal tumor tissues. Conversely, dioscin improved the secretion of pro‐inflammatory cytokines (IL‐6, TNFα, and IL‐1β), and the phagocytic capacity of tumor‐associated macrophages by increasing M2‐to‐M1 phenotype transition. More strikingly, even in Cx43 functional deficient B16 and RAW264.7 cells, dioscin still dramatically reversed the aggravated tumor malignancy and reduced macrophage phagocytic activity. Two classical metastasis animal models were utilized in vivo and results showed that dioscin showed significant anti‐metastatic effects, which is closely related to the expression of Cx43 either in in situ tumor or metastatic lung nodes. In conclusion, dioscin targets Cx43 to suppress the tumor cell malignancy and activate macrophage sensitivity, thereby targeting melanoma microenvironment. Connexin 43 (Cx43), a vital gap junction protein in tumor microenvironment (TME), is a novel molecular target for melanoma chemotherapeutics due to its tumor suppressive function. Dioscin, an herbal steroidal saponin, exerts anti‐tumor effects while the underlying mechanism is unclear. Using WB, FACS, and immunofluorescence methodologies, we found dioscin significantly activated the transcription and translation of Cx43 via the retinoid acid signaling pathway and simultaneously enhanced the transporting function of Cx43. Through stimulating Cx43, dioscin remarkably suppressed the migratory and invasive capacities of B16 cells, and notably decreased pluripotency markers of cancer stem cells and epithelial‐to‐mesenchymal transition in B16 cells and animal tumor tissues. Conversely, dioscin improved the secretion of pro‐inflammatory cytokines (IL‐6, TNFα, and IL‐1β), and the phagocytic capacity of tumor‐associated macrophages by increasing M2‐to‐M1 phenotype transition. More strikingly, even in Cx43 functional deficient B16 and RAW264.7 cells, dioscin still dramatically reversed the aggravated tumor malignancy and reduced macrophage phagocytic activity. Two classical metastasis animal models were utilized in vivo and results showed that dioscin showed significant anti‐metastatic effects, which is closely related to the expression of Cx43 either in in situ tumor or metastatic lung nodes. In conclusion, dioscin targets Cx43 to suppress the tumor cell malignancy and activate macrophage sensitivity, thereby targeting melanoma microenvironment. What's new? New results reveal how an Chinese herbal medicine component acts against melanoma. Dioscin, a natural steroidal saponin, induces apoptosis in breast cancer as well as boosting production of pro‐inflammatory cytokines. These authors investigated the chemical's effect on connexin 43, a tumor suppressing protein found in the microenvironment that is frequently silenced in metastatic melanoma. Dioscin remarkably enhanced the expression of connexin 43, as well as boosting its ability to reverse the metastatic transition. Treatment with dioscin also enhanced the immune response, spurring macrophages to attack the tumor cells. Connexin 43 (Cx43), a vital gap junction protein in tumor microenvironment (TME), is a novel molecular target for melanoma chemotherapeutics due to its tumor suppressive function. Dioscin, an herbal steroidal saponin, exerts anti‐tumor effects while the underlying mechanism is unclear. Using WB, FACS, and immunofluorescence methodologies, we found dioscin significantly activated the transcription and translation of Cx43 via the retinoid acid signaling pathway and simultaneously enhanced the transporting function of Cx43. Through stimulating Cx43, dioscin remarkably suppressed the migratory and invasive capacities of B16 cells, and notably decreased pluripotency markers of cancer stem cells and epithelial‐to‐mesenchymal transition in B16 cells and animal tumor tissues. Conversely, dioscin improved the secretion of pro‐inflammatory cytokines (IL‐6, TNFα, and IL‐1β), and the phagocytic capacity of tumor‐associated macrophages by increasing M2‐to‐M1 phenotype transition. More strikingly, even in Cx43 functional deficient B16 and RAW264.7 cells, dioscin still dramatically reversed the aggravated tumor malignancy and reduced macrophage phagocytic activity. Two classical metastasis animal models were utilized in vivo and results showed that dioscin showed significant anti‐metastatic effects, which is closely related to the expression of Cx43 either in in situ tumor or metastatic lung nodes. In conclusion, dioscin targets Cx43 to suppress the tumor cell malignancy and activate macrophage sensitivity, thereby targeting melanoma microenvironment. What's new? New results reveal how an Chinese herbal medicine component acts against melanoma. Dioscin, a natural steroidal saponin, induces apoptosis in breast cancer as well as boosting production of pro‐inflammatory cytokines. These authors investigated the chemical's effect on connexin 43, a tumor suppressing protein found in the microenvironment that is frequently silenced in metastatic melanoma. Dioscin remarkably enhanced the expression of connexin 43, as well as boosting its ability to reverse the metastatic transition. Treatment with dioscin also enhanced the immune response, spurring macrophages to attack the tumor cells. Connexin 43 (Cx43), a vital gap junction protein in tumor microenvironment (TME), is a novel molecular target for melanoma chemotherapeutics due to its tumor suppressive function. Dioscin, an herbal steroidal saponin, exerts anti-tumor effects while the underlying mechanism is unclear. Using WB, FACS, and immunofluorescence methodologies, we found dioscin significantly activated the transcription and translation of Cx43 via the retinoid acid signaling pathway and simultaneously enhanced the transporting function of Cx43. Through stimulating Cx43, dioscin remarkably suppressed the migratory and invasive capacities of B16 cells, and notably decreased pluripotency markers of cancer stem cells and epithelial-to-mesenchymal transition in B16 cells and animal tumor tissues. Conversely, dioscin improved the secretion of pro-inflammatory cytokines (IL-6, TNFα, and IL-1β), and the phagocytic capacity of tumor-associated macrophages by increasing M2-to-M1 phenotype transition. More strikingly, even in Cx43 functional deficient B16 and RAW264.7 cells, dioscin still dramatically reversed the aggravated tumor malignancy and reduced macrophage phagocytic activity. Two classical metastasis animal models were utilized in vivo and results showed that dioscin showed significant anti-metastatic effects, which is closely related to the expression of Cx43 either in in situ tumor or metastatic lung nodes. In conclusion, dioscin targets Cx43 to suppress the tumor cell malignancy and activate macrophage sensitivity, thereby targeting melanoma microenvironment.Connexin 43 (Cx43), a vital gap junction protein in tumor microenvironment (TME), is a novel molecular target for melanoma chemotherapeutics due to its tumor suppressive function. Dioscin, an herbal steroidal saponin, exerts anti-tumor effects while the underlying mechanism is unclear. Using WB, FACS, and immunofluorescence methodologies, we found dioscin significantly activated the transcription and translation of Cx43 via the retinoid acid signaling pathway and simultaneously enhanced the transporting function of Cx43. Through stimulating Cx43, dioscin remarkably suppressed the migratory and invasive capacities of B16 cells, and notably decreased pluripotency markers of cancer stem cells and epithelial-to-mesenchymal transition in B16 cells and animal tumor tissues. Conversely, dioscin improved the secretion of pro-inflammatory cytokines (IL-6, TNFα, and IL-1β), and the phagocytic capacity of tumor-associated macrophages by increasing M2-to-M1 phenotype transition. More strikingly, even in Cx43 functional deficient B16 and RAW264.7 cells, dioscin still dramatically reversed the aggravated tumor malignancy and reduced macrophage phagocytic activity. Two classical metastasis animal models were utilized in vivo and results showed that dioscin showed significant anti-metastatic effects, which is closely related to the expression of Cx43 either in in situ tumor or metastatic lung nodes. In conclusion, dioscin targets Cx43 to suppress the tumor cell malignancy and activate macrophage sensitivity, thereby targeting melanoma microenvironment. |
Author | Du, Biaoyan Wang, Wensheng Wang, Haojia Kou, Yu Lu, Linlin Ji, Liyan Zheng, Hongming Zou, Juan Liu, Linxin Qi, Xiaoxiao Liu, Zhongqiu |
Author_xml | – sequence: 1 givenname: Yu surname: Kou fullname: Kou, Yu organization: School of Basic Medical Sciences, Guangzhou University of Chinese Medicine – sequence: 2 givenname: Liyan surname: Ji fullname: Ji, Liyan organization: International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine – sequence: 3 givenname: Haojia surname: Wang fullname: Wang, Haojia organization: International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine – sequence: 4 givenname: Wensheng surname: Wang fullname: Wang, Wensheng organization: International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine – sequence: 5 givenname: Hongming surname: Zheng fullname: Zheng, Hongming organization: International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine – sequence: 6 givenname: Juan surname: Zou fullname: Zou, Juan organization: International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine – sequence: 7 givenname: Linxin surname: Liu fullname: Liu, Linxin organization: International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine – sequence: 8 givenname: Xiaoxiao surname: Qi fullname: Qi, Xiaoxiao organization: International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine – sequence: 9 givenname: Zhongqiu surname: Liu fullname: Liu, Zhongqiu organization: International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine – sequence: 10 givenname: Biaoyan surname: Du fullname: Du, Biaoyan email: dubiaoyan@gzucm.edu.cn organization: School of Basic Medical Sciences, Guangzhou University of Chinese Medicine – sequence: 11 givenname: Linlin orcidid: 0000-0002-8221-4613 surname: Lu fullname: Lu, Linlin email: lllu@gzucm.edu.cn organization: International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28677156$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1v1DAQhi1URLeFA38AWeICh7R2_JkjWvFRVMQFzpFjTxavEjvYSSH8ery7hUMlOI0887wz43kv0FmIARB6TskVJaS-9nt7xYhW9SO0oaRRFampOEObUiOVokyeo4uc94RQKgh_gs5rLZWiQm7Quo0hwE8fMGd4mRLslsHMPgbcrdj5mG0p-fDNd37OeITBhDgaPKW4S5DzAbzzBudlmo7vsMOjGfwumGBXbIIrYrfYQ_4TxVMcTPK_jgOeose9GTI8u4-X6Ou7t1-2H6rbz-9vtm9uK8sFryvHRW962oOTrCE17xuQXHdSEOesAdmLnpOmA1C6oYwrJYRSjDhoaMOcEOwSvTr1LTt_XyDP7eizhaH8BOKSW9pQyZTWWhX05QN0H5cUynaFYkQqzTQp1It7aulGcO2U_GjS2v45agFenwCbYs4J-r8IJe3BsLYY1h4NK-z1A9b6-XifORk__E_xww-w_rt1e_Nxe1L8Bhmup2E |
CitedBy_id | crossref_primary_10_1002_jcp_29197 crossref_primary_10_1016_j_lfs_2020_118182 crossref_primary_10_1016_j_lfs_2018_08_039 crossref_primary_10_1002_cam4_2108 crossref_primary_10_1016_j_phymed_2019_152968 crossref_primary_10_3389_fonc_2021_593587 crossref_primary_10_1007_s10616_021_00454_7 crossref_primary_10_1016_j_intimp_2023_109839 crossref_primary_10_1111_pcmr_12945 crossref_primary_10_3390_ijms23115918 crossref_primary_10_1016_j_phrs_2021_105983 crossref_primary_10_3389_fonc_2019_01209 crossref_primary_10_3390_ijms19041159 crossref_primary_10_3389_fmed_2022_880326 crossref_primary_10_3748_wjg_v28_i40_5845 crossref_primary_10_1016_j_phymed_2022_154559 crossref_primary_10_1155_2022_6422500 crossref_primary_10_1016_j_phrs_2018_09_022 crossref_primary_10_2174_1389450124666230719105147 crossref_primary_10_1111_jcmm_15563 crossref_primary_10_1016_j_biopha_2022_112973 crossref_primary_10_1186_s12964_024_01642_6 crossref_primary_10_1016_j_bbcan_2020_188380 crossref_primary_10_3389_fphar_2023_1186712 crossref_primary_10_3390_cells14060403 crossref_primary_10_1007_s12032_024_02572_6 crossref_primary_10_3389_fvets_2021_670451 crossref_primary_10_53879_id_60_04_11812 crossref_primary_10_1016_j_prmcm_2024_100423 crossref_primary_10_4103_2311_8571_353503 crossref_primary_10_3390_ijms24032600 crossref_primary_10_1177_1074248418801567 crossref_primary_10_1097_CAD_0000000000001179 crossref_primary_10_3390_biology12020204 crossref_primary_10_7717_peerj_7760 crossref_primary_10_1371_journal_pone_0272781 crossref_primary_10_1002_biof_1815 crossref_primary_10_1080_08923973_2024_2425028 crossref_primary_10_1002_jcp_29969 crossref_primary_10_1136_jitc_2020_001341 crossref_primary_10_3390_molecules24122222 crossref_primary_10_1139_bcb_2019_0137 crossref_primary_10_1016_j_heliyon_2024_e29215 crossref_primary_10_3389_fphar_2023_1159985 crossref_primary_10_1021_acsabm_0c01388 crossref_primary_10_1007_s11101_020_09661_0 crossref_primary_10_1016_j_ejphar_2019_03_050 crossref_primary_10_1016_j_intimp_2021_108015 crossref_primary_10_1016_j_phrs_2021_105796 crossref_primary_10_3390_ijms21239119 crossref_primary_10_3892_etm_2022_11577 |
Cites_doi | 10.4049/jimmunol.181.12.8534 10.1016/j.ejca.2015.09.013 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.0.CO;2-0 10.1038/cddis.2013.560 10.1254/jphs.FP0051023 10.1016/j.biochi.2013.11.015 10.4049/jimmunol.1301297 10.1038/bjc.2015.162 10.1016/j.molonc.2013.02.009 10.1016/S0140-6736(13)60802-8 10.1002/jcp.24235 10.1007/s00204-013-1148-8 10.1007/s00418-009-0654-5 10.1200/JCO.2013.53.1590 10.3322/caac.21332 10.1016/j.toxlet.2012.08.005 10.1158/0008-5472.CAN-08-0041 10.2174/1381612821666141211115611 10.4049/jimmunol.1202884 10.1016/j.yexcr.2007.09.010 10.1159/000362978 10.1146/annurev.bi.65.070196.002355 10.1002/jcp.24241 10.1074/jbc.M305072200 10.1097/PAT.0b013e328363b3bd 10.1097/PGP.0b013e3181c3c57f 10.1177/107327480901600307 10.1074/jbc.M409564200 10.18632/oncotarget.1764 10.1016/j.jid.2015.11.013 10.1158/1078-0432.CCR-14-1554 10.1016/j.canlet.2014.05.008 10.1007/978-3-319-22539-5_8 10.1111/pcmr.12120 10.1002/1098-2744(200006)28:2<119::AID-MC8>3.0.CO;2-N 10.1038/nm.2667 10.1007/s10495-014-0994-z 10.1074/jbc.M109.053348 10.1101/gad.191999.112 10.1200/JCO.2004.08.140 10.1023/B:HIJO.0000032362.35354.bb 10.1038/nrc2841 10.18632/oncotarget.3449 10.1074/jbc.M113.507228 |
ContentType | Journal Article |
Copyright | 2017 UICC 2017 UICC. |
Copyright_xml | – notice: 2017 UICC – notice: 2017 UICC. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 |
DOI | 10.1002/ijc.30872 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-0215 |
EndPage | 1703 |
ExternalDocumentID | 28677156 10_1002_ijc_30872 IJC30872 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Bureau for Science and Information Technology of Guangzhou Municipality funderid: ID# 201509010004 – fundername: Natural Science Foundation of Guangdong Province, China funderid: ID # 2015A030312012; #2016A050502052; # 2015B020233015 |
GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RX1 RYL SUPJJ TEORI UB1 UDS V2E V8K V9Y W2D W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGYGG CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 |
ID | FETCH-LOGICAL-c4542-d45faf1fed639024f9e648b650ddcae6f5f409bee78913477557730de9193d553 |
IEDL.DBID | DR2 |
ISSN | 0020-7136 1097-0215 |
IngestDate | Fri Jul 11 00:59:21 EDT 2025 Sun Jul 13 03:25:03 EDT 2025 Thu Apr 03 07:03:12 EDT 2025 Thu Apr 24 22:53:42 EDT 2025 Tue Jul 01 02:28:21 EDT 2025 Wed Jan 22 16:28:33 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | melanoma dioscin connexin 43 macrophage-induced epithelial-to-mesenchymal transition |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 UICC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4542-d45faf1fed639024f9e648b650ddcae6f5f409bee78913477557730de9193d553 |
Notes | All authors declare that no conflicts of interest exist. Conflict of Interest Contributed equally to this paper. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-8221-4613 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.30872 |
PMID | 28677156 |
PQID | 1930678380 |
PQPubID | 105430 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_1916378887 proquest_journals_1930678380 pubmed_primary_28677156 crossref_primary_10_1002_ijc_30872 crossref_citationtrail_10_1002_ijc_30872 wiley_primary_10_1002_ijc_30872_IJC30872 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 15 October 2017 |
PublicationDateYYYYMMDD | 2017-10-15 |
PublicationDate_xml | – month: 10 year: 2017 text: 15 October 2017 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | International journal of cancer |
PublicationTitleAlternate | Int J Cancer |
PublicationYear | 2017 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2004; 22 2010; 10 2013; 26 2015; 6 2000; 28 2013; 45 2013; 228 2016; 53 2016; 167 2010; 285 2012; 18 2014; 192 2013; 7 2014; 352 2003; 278 2014; 88 2008; 181 2007; 313 2005; 280 2014; 5 2012; 1 2015; 113 2010; 29 2004; 35 2015; 21 2010; 133 2008; 68 2014; 19 2016; 136 2012; 26 1999; 70 2012; 214 2012; 4 2014; 383 2009; 16 2006; 101 2014; 34 1996; 65 2014; 101 2013; 190 2014; 32 2016; 66 2014; 289 Quatromoni JG (e_1_2_6_8_1) 2012; 4 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_12_1 e_1_2_6_33_1 Kolarcik CL (e_1_2_6_34_1) 2012; 1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_42_1 e_1_2_6_43_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_40_1 e_1_2_6_9_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_28_1 e_1_2_6_45_1 e_1_2_6_27_1 e_1_2_6_46_1 e_1_2_6_26_1 e_1_2_6_47_1 |
References_xml | – volume: 32 start-page: 3771 year: 2014 end-page: 8 article-title: Southwest oncology group S0008: a phase III trial of high‐dose interferon Alfa‐2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin‐2 and interferon in patients with high‐risk melanoma—an intergroup study of cancer and leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group publication-title: JCO. – volume: 35 start-page: 309 year: 2004 end-page: 18 article-title: The role of altered cell‐cell communication in melanoma progression publication-title: J Mol Histol. – volume: 6 start-page: 11640 year: 2015 end-page: 51 article-title: Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration publication-title: Oncotarget – volume: 181 start-page: 8534 year: 2008 end-page: 43 article-title: A role for connexin43 in macrophage phagocytosis and host survival after bacterial peritoneal infection publication-title: J Immunol. – volume: 34 start-page: 213 year: 2014 end-page: 43 article-title: Cell‐cell communication in the tumor microenvironment, carcinogenesis, and anticancer treatment publication-title: Cell Physiol Biochem. – volume: 10 start-page: 435 year: 2010 end-page: 41 article-title: Implications and challenges of connexin connections to cancer publication-title: Nat Rev Cancer. – volume: 22 start-page: 1293 year: 2004 end-page: 300 article-title: Determinants of outcome in melanoma patients with cerebral metastases publication-title: JCO. – volume: 228 start-page: 853 year: 2013 end-page: 9 article-title: A dominant negative Cx43 mutant differentially affects tumorigenic and invasive properties in human metastatic melanoma cells publication-title: J Cell Physiol. – volume: 88 start-page: 739 year: 2014 end-page: 53 article-title: Protective effects of dioscin against alcohol‐induced liver injury publication-title: Arch Toxicol. – volume: 5 start-page: e1023 year: 2014 article-title: A cell‐penetrating peptide based on the interaction between c‐Src and connexin43 reverses glioma stem cell phenotype publication-title: Cell Death Dis. – volume: 26 start-page: 746 year: 2013 end-page: 54 article-title: Could pericytic mimicry represent another type of melanoma cell plasticity with embryonic properties? publication-title: Pigment Cell Melanoma Res. – volume: 7 start-page: 283 year: 2013 end-page: 96 article-title: Rebuilding cancer metastasis in the mouse publication-title: Mol Oncol. – volume: 313 start-page: 4083 year: 2007 end-page: 90 article-title: Phosphorylation of connexin43 induced by Src: regulation of gap junctional communication between transformed cells publication-title: Exp Cell Res. – volume: 167 start-page: 209 year: 2016 end-page: 29 article-title: Chemotherapy for Melanoma publication-title: Cancer Treat Res. – volume: 285 start-page: 10761 year: 2010 end-page: 76 article-title: E‐cadherin differentially regulates the assembly of Connexin 43 and Connexin 32 into gap junctions in human squamous carcinoma cells publication-title: J Biol Chem. – volume: 53 start-page: 125 year: 2016 end-page: 34 article-title: Survival of patients with advanced metastatic melanoma: the impact of novel therapies publication-title: Eur J Cancer – volume: 4 start-page: 376 year: 2012 end-page: 89 article-title: Tumor‐associated macrophages: function, phenotype, and link to prognosis in human lung cancer publication-title: Am J Translat Res. – volume: 45 start-page: 443 year: 2013 end-page: 52 article-title: Melanoma's connections to the tumour microenvironment publication-title: Pathology – volume: 228 start-page: 903 year: 2013 end-page: 10 article-title: Retinoic acid regulates gap junction intercellular communication in human endometrial stromal cells through modulation of the phosphorylation status of connexin 43 publication-title: J Cell Physiol. – volume: 26 start-page: 1131 year: 2012 end-page: 55 article-title: Melanoma: from mutations to medicine publication-title: Genes Dev. – volume: 192 start-page: 1313 year: 2014 end-page: 9 article-title: Gap junction intercellular communications regulate NK cell activation and modulate NK cytotoxic capacity publication-title: J Immunol. – volume: 113 start-page: 259 year: 2015 end-page: 67 article-title: Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity publication-title: Br J Cancer – volume: 19 start-page: 1165 year: 2014 end-page: 75 article-title: Dioscin induces caspase‐independent apoptosis through activation of apoptosis‐inducing factor in breast cancer cells publication-title: Apoptosis Int J Program Cell Death – volume: 101 start-page: 1 year: 2014 end-page: 9 article-title: Connexin a check‐point component of cell apoptosis in normal and physiopathological conditions publication-title: Biochimie – volume: 190 start-page: 4830 year: 2013 end-page: 5 article-title: Connexin43 is dispensable for phagocytosis publication-title: J Immunol. – volume: 214 start-page: 69 year: 2012 end-page: 80 article-title: Dioscin, a natural steroid saponin, shows remarkable protective effect against acetaminophen‐induced liver damage in vitro and in vivo publication-title: Toxicol Lett. – volume: 5 start-page: 1621 year: 2014 end-page: 34 article-title: Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43‐mediated gap junctional intercellular communication publication-title: Oncotarget – volume: 21 start-page: 1279 year: 2015 end-page: 91 article-title: The epithelial‐mesenchymal transition and cancer stem cells: functional and mechanistic links publication-title: CPD. – volume: 352 start-page: 160 year: 2014 end-page: 8 article-title: Tumor‐associated macrophages promote cancer stem cell‐like properties via transforming growth factor‐beta1‐induced epithelial‐mesenchymal transition in hepatocellular carcinoma publication-title: Cancer Lett. – volume: 289 start-page: 1592 year: 2014 end-page: 603 article-title: Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo publication-title: J Biol Chem. – volume: 65 start-page: 475 year: 1996 end-page: 502 article-title: Connexins, connexons, and intercellular communication publication-title: Annu Rev Biochem. – volume: 29 start-page: 358 year: 2010 end-page: 65 article-title: Aberrant distributions and relationships among E‐cadherin, beta‐catenin, and connexin 26 and 43 in endometrioid adenocarcinomas publication-title: Int J Gynecol Pathol. – volume: 21 start-page: 1652 year: 2015 end-page: 64 article-title: BRAF inhibition stimulates melanoma‐associated macrophages to drive tumor growth publication-title: Clin Cancer Res. – volume: 383 start-page: 816 year: 2014 end-page: 27 article-title: Cutaneous melanoma publication-title: Lancet – volume: 68 start-page: 4500 year: 2008 end-page: 5 article-title: Development of a preclinical model of spontaneous human melanoma central nervous system metastasis publication-title: Cancer Res. – volume: 280 start-page: 11458 year: 2005 end-page: 66 article-title: Oculodentodigital dysplasia‐causing connexin 43 mutants are non‐functional and exhibit dominant effects on wild‐type connexin 43 publication-title: J Biol Chem. – volume: 133 start-page: 113 year: 2010 end-page: 24 article-title: Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironment publication-title: Histochem Cell Biol. – volume: 136 start-page: 372 year: 2016 end-page: 7 article-title: The role of neutrophilic inflammation, angiotropism, and pericytic mimicry in melanoma progression and metastasis publication-title: J Invest Dermatol. – volume: 278 start-page: 44852 year: 2003 end-page: 6 article-title: The gap junction‐independent tumor‐suppressing effect of connexin 43 publication-title: J Biol Chem. – volume: 1 start-page: 130 year: 2012 end-page: 45 article-title: Retinoid signaling alterations in amyotrophic lateral sclerosis publication-title: Am J Neurodegen Dis. – volume: 28 start-page: 119 year: 2000 end-page: 27 article-title: Identification of tumor‐suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles publication-title: Mol Carcinog. – volume: 18 start-page: 572 year: 2012 end-page: 9 article-title: Macrophage‐derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease publication-title: Nat Med. – volume: 66 start-page: 7 year: 2016 end-page: 30 article-title: Cancer statistics, 2016 publication-title: CA Cancer J Clin. – volume: 101 start-page: 214 year: 2006 end-page: 22 article-title: Acetylcholine inhibits the hypoxia‐induced reduction of connexin43 protein in rat cardiomyocytes publication-title: J Pharmacol Sci. – volume: 16 start-page: 248 year: 2009 end-page: 55 article-title: Diagnosis and treatment of melanoma brain metastasis: a literature review publication-title: Cancer Control – volume: 70 start-page: 21 year: 1999 end-page: 4 article-title: Reduced connexin43 expression in high‐grade human brain glioma cells publication-title: J Surg Oncol. – ident: e_1_2_6_12_1 doi: 10.4049/jimmunol.181.12.8534 – ident: e_1_2_6_20_1 doi: 10.1016/j.ejca.2015.09.013 – ident: e_1_2_6_13_1 doi: 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.0.CO;2-0 – ident: e_1_2_6_42_1 doi: 10.1038/cddis.2013.560 – ident: e_1_2_6_30_1 doi: 10.1254/jphs.FP0051023 – ident: e_1_2_6_37_1 doi: 10.1016/j.biochi.2013.11.015 – ident: e_1_2_6_11_1 doi: 10.4049/jimmunol.1301297 – ident: e_1_2_6_19_1 doi: 10.1038/bjc.2015.162 – ident: e_1_2_6_25_1 doi: 10.1016/j.molonc.2013.02.009 – ident: e_1_2_6_47_1 doi: 10.1016/S0140-6736(13)60802-8 – ident: e_1_2_6_18_1 doi: 10.1002/jcp.24235 – ident: e_1_2_6_24_1 doi: 10.1007/s00204-013-1148-8 – ident: e_1_2_6_6_1 doi: 10.1007/s00418-009-0654-5 – ident: e_1_2_6_46_1 doi: 10.1200/JCO.2013.53.1590 – ident: e_1_2_6_2_1 doi: 10.3322/caac.21332 – ident: e_1_2_6_22_1 doi: 10.1016/j.toxlet.2012.08.005 – ident: e_1_2_6_26_1 doi: 10.1158/0008-5472.CAN-08-0041 – ident: e_1_2_6_41_1 doi: 10.2174/1381612821666141211115611 – ident: e_1_2_6_43_1 doi: 10.4049/jimmunol.1202884 – ident: e_1_2_6_9_1 doi: 10.1016/j.yexcr.2007.09.010 – ident: e_1_2_6_35_1 doi: 10.1159/000362978 – ident: e_1_2_6_36_1 doi: 10.1146/annurev.bi.65.070196.002355 – ident: e_1_2_6_33_1 doi: 10.1002/jcp.24241 – ident: e_1_2_6_14_1 doi: 10.1074/jbc.M305072200 – ident: e_1_2_6_10_1 doi: 10.1097/PAT.0b013e328363b3bd – ident: e_1_2_6_39_1 doi: 10.1097/PGP.0b013e3181c3c57f – ident: e_1_2_6_4_1 doi: 10.1177/107327480901600307 – ident: e_1_2_6_27_1 doi: 10.1074/jbc.M409564200 – ident: e_1_2_6_38_1 doi: 10.18632/oncotarget.1764 – ident: e_1_2_6_5_1 doi: 10.1016/j.jid.2015.11.013 – ident: e_1_2_6_21_1 doi: 10.1158/1078-0432.CCR-14-1554 – ident: e_1_2_6_31_1 doi: 10.1016/j.canlet.2014.05.008 – ident: e_1_2_6_45_1 doi: 10.1007/978-3-319-22539-5_8 – ident: e_1_2_6_7_1 doi: 10.1111/pcmr.12120 – ident: e_1_2_6_17_1 doi: 10.1002/1098-2744(200006)28:2<119::AID-MC8>3.0.CO;2-N – volume: 4 start-page: 376 year: 2012 ident: e_1_2_6_8_1 article-title: Tumor‐associated macrophages: function, phenotype, and link to prognosis in human lung cancer publication-title: Am J Translat Res. – ident: e_1_2_6_29_1 doi: 10.1038/nm.2667 – ident: e_1_2_6_23_1 doi: 10.1007/s10495-014-0994-z – volume: 1 start-page: 130 year: 2012 ident: e_1_2_6_34_1 article-title: Retinoid signaling alterations in amyotrophic lateral sclerosis publication-title: Am J Neurodegen Dis. – ident: e_1_2_6_40_1 doi: 10.1074/jbc.M109.053348 – ident: e_1_2_6_44_1 doi: 10.1101/gad.191999.112 – ident: e_1_2_6_3_1 doi: 10.1200/JCO.2004.08.140 – ident: e_1_2_6_15_1 doi: 10.1023/B:HIJO.0000032362.35354.bb – ident: e_1_2_6_16_1 doi: 10.1038/nrc2841 – ident: e_1_2_6_28_1 doi: 10.18632/oncotarget.3449 – ident: e_1_2_6_32_1 doi: 10.1074/jbc.M113.507228 |
SSID | ssj0011504 |
Score | 2.4744773 |
Snippet | Connexin 43 (Cx43), a vital gap junction protein in tumor microenvironment (TME), is a novel molecular target for melanoma chemotherapeutics due to its tumor... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1690 |
SubjectTerms | Animal models Animals Apoptosis Breast cancer Cancer Connexin 43 Connexin 43 - metabolism Cytokines dioscin Diosgenin - analogs & derivatives Diosgenin - pharmacology Female Flow cytometry Herbal medicine Immune response Immunofluorescence Inflammation Interleukin 1 Interleukin 6 Invasiveness Macrophages macrophage‐induced epithelial‐to‐mesenchymal transition Malignancy Medical research Melanoma Melanoma, Experimental - drug therapy Melanoma, Experimental - metabolism Melanoma, Experimental - pathology Mesenchyme Metastases Metastasis Mice Mice, Inbred C57BL Molecular Targeted Therapy Phagocytes Pluripotency Polarization RAW 264.7 Cells Signal transduction Stem cells Transcription Tumor cells Up-Regulation - drug effects |
Title | Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.30872 https://www.ncbi.nlm.nih.gov/pubmed/28677156 https://www.proquest.com/docview/1930678380 https://www.proquest.com/docview/1916378887 |
Volume | 141 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDhWXlpY-FmhlUA-9ZMkmdrIRpwoVAdJyqIrEoVLkJ03LelfsBnX765mJk1T0ISFuUWInjsfj-cYefwPw3spUUjrySKkRj7jT40gWKo10EWtlheaZpgPOk_Ps5IKfXYrLNTjszsIEfoh-wY00o5mvScGlWhz8Jg2tvush0dnR_EuxWgSIPvfUUQR0WgbmOEJHLOtYheLkoK953xb9BTDv49XG4Bw_g69dU0OcyY9hvVRD_esPFsdH_ssmPG2BKPsYRs5zWLP-BTyZtFvtW7BqQmB-Vp7xlNXzm5CzHqXI1IqZijgwPav8t0pVywWb2mvpZ1PJmnivwPXBbivJFvU8hNr6KzZFzH9FBB8rJr3ByqbWdH8yYnPysNsjoS_h4vjTl6OTqM3TEGkueBIZLpx0I2cNwh20-a6wGR8rxH7GaGkzJxx6kcranPZEeZ4LkePEYmyB6NEIkb6CdT_z9g0wa7EblEoTh69A41qYOMUhw1ODbtnYyQF86CRW6pbEnHJpXJeBfjkpsSvLpisHsN8XnQfmjn8V2u3EXrbKuyixVWTD03E8gL3-Maod7aVIb2c1lUEgS8sH-QBeh-HSfyUhjkD0i7GxjdD___ny9Oyoudh-eNEd2EgIWlBUjdiF9eVNbd8iMFqqd40G3AF27QqU |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQIu5Q0LBQziwCXbbGInG4kLKlTb0u0BtVIvKPKzhHa9q-4Gsfx6ZuIkqDwkxC1K7MTxeDzf2ONvAF5ZmUpKRx4pNeIRd3ocyUKlkS5irazQPNN0wHl6lE1O-MGpON2AN91ZmMAP0S-4kWY08zUpOC1I7_xkDa2-6CHx2eEEfI0yelP-gncfe_IogjotB3McoSuWdbxCcbLTV71qjX6DmFcRa2Ny9m7Bp66xIdLkfFiv1FB__4XH8X__5jZstViUvQ2D5w5sWH8Xrk_b3fZ7sG6iYL5VnvGU1YvLkLYeBcnUmpmKaDA9q_znSlWrJZvZC-nnM8makK9A98G-VpIt60WItvVnbIaw_4w4PtZMeoOVTa3p_nTEFuRkt6dC78PJ3vvj3UnUpmqINBc8iQwXTrqRswYRD5p9V9iMjxXCP2O0tJkTDh1JZW1O26I8z4XIcW4xtkAAaYRIH8Cmn3v7CJi12A1KpYnDV6B9LUyc4qjhqUHPbOzkAF53Iit1y2NO6TQuysDAnJTYlWXTlQN42RddBPKOPxXa7uRetvq7LLFVZMbTcTyAF_1j1DzaTpHezmsqg1iWVhDyATwM46X_SkI0gegaY2Mbqf_98-X-wW5z8fjfiz6HG5Pj6WF5uH_04QncTAhpUJCN2IbN1WVtnyJOWqlnjTr8AAowDq4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VrVRxgfLstgUM4sAl22xiJxtxqgqrtrAVQlTqASnyswS63qi7QSy_vjN5ofKQELcosRPH4_F8Y4-_AXhhZSwpHXmg1IgH3OlxIDMVBzoLtbJC80TTAefpaXJ0xk_OxfkavOrOwjT8EP2CG2lGPV-TgpfG7f8kDS2-6CHR2eH8u8ETVBZCRB967ihCOi0FcxigJ5Z0tEJhtN9XvWmMfkOYNwFrbXEmd-BT19Ym0OTrsFqqof7xC43jf_7MFtxukSg7aIbOXViz_h5sTtu99vuwqmNgvhee8ZhV5VWTtB7FyNSKmYJIMD0r_OdCFcsFm9lL6eczyeqAr4bsg30rJFtUZRNr6y_YDEH_BTF8rJj0BiubStP96YiV5GK3Z0IfwNnkzcfDo6BN1BBoLngUGC6cdCNnDeIdNPouswkfKwR_xmhpEyccupHK2pQ2RXmaCpHizGJshvDRCBE_hHU_93YbmLXYDUrFkcNXoHXNTBjjmOGxQb9s7OQAXnYSy3XLYk7JNC7zhn85yrEr87orB_C8L1o21B1_KrTXiT1vtXeRY6vIiMfjcADP-seod7SZIr2dV1QGkSytH6QDeNQMl_4rEZEEomOMja2F_vfP58cnh_XFzr8XfQqb719P8nfHp2934VZEMIMibMQerC-vKvsYQdJSPamV4Rr1ig1m |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Connexin+43+upregulation+by+dioscin+inhibits+melanoma+progression+via+suppressing+malignancy+and+inducing+M1+polarization&rft.jtitle=International+journal+of+cancer&rft.au=Kou%2C+Yu&rft.au=Ji%2C+Liyan&rft.au=Wang%2C+Haojia&rft.au=Wang%2C+Wensheng&rft.date=2017-10-15&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=141&rft.issue=8&rft.spage=1690&rft.epage=1703&rft_id=info:doi/10.1002%2Fijc.30872&rft.externalDBID=10.1002%252Fijc.30872&rft.externalDocID=IJC30872 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon |